Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.080
-0.080 (-3.70%)
Mar 20, 2026, 2:52 PM EDT - Market open
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $23.26 million as of March 20, 2026. Its market cap has decreased by -44.55% in one year.
Market Cap
23.26M
Enterprise Value
11.80M
1-Year Change
-44.55%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $30.33M to $23.26M, a decrease of -23.30%. That is a compound annual growth rate of -4.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 24.16M | -28.71% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xilio Therapeutics | 27.86M |
| Barinthus Biotherapeutics | 27.77M |
| NeuroSense Therapeutics | 27.33M |
| IGC Pharma | 26.84M |
| Cue Biopharma | 26.51M |
| Enlivex | 26.24M |
| Boundless Bio | 25.77M |
| Senti Biosciences | 25.77M |